1032 etrasimod induction therapy in moderately to severely active crohn's disease: results from a phase 2, randomized, double-blind substudy

Gastroenterology(2023)

引用 0|浏览10
暂无评分
关键词
severely active crohns,etrasimod induction therapy,double-blind
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要